Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Neurology|July 10, 2015
Diabetes and cognitive decline in a French cohort of patients infected with HIV-1Carole Dufouil, Laura Richert, Rodolphe Thiébaut, et al.Plos One|January 30, 2014
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureMarie-Anne Vandenhende, Pantxika Bellecave, Patricia Recordon-Pinson, et al.AIDS (London, England)|December 19, 2021
Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patientsHélène Chaussade, Fabien Le Marec, Gaëlle Coureau, et al.Antimicrobial Agents and Chemotherapy|February 14, 2007
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patientsIsabelle Pellegrin, Dominique Breilh, Gaelle Coureau, et al.Health and Quality of Life Outcomes|July 12, 2020
Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary studyDiana Barger, Mojgan Hessamfar, Didier Neau, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected PatientsIsabelle Poizot-Martin, Eric Rosenthal, Camille Gilbert, et al.Scientific Reports|April 17, 2022
A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general populationVictor Hémar, Mojgan Hessamfar, Didier Neau, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine CohortDidier Neau, Maria Winnock, Laurent Castéra, et al.International Journal of Antimicrobial Agents|December 5, 2022
Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007-2018Elsa Nyamankolly, Pantxika Bellecave, Linda Wittkop, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Urolithiasis in HIV-positive patients treated with atazanavirCarine Couzigou, Michel Daudon, Jean Luc Meynard, et al.Pageof 9